Found 9 matching trials
Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa PHASE1 This is a single-center study to investigate the effects of a topical cream...
Show More Location
University of Miami Department of Dermatology
Learn More & Join Trial
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors PHASE1 This is a Phase 1a/b multicenter, open-label, non-randomized, dose-escalati...
Show More Location
Palo Alto Medical Foundation
Learn More & Join Trial
A Safety Study of Orally Administered BPM31510 in Healthy Subjects PHASE1 This is an open-label, Phase I study of the bioavailability and safety of B...
Show More Learn More & Join Trial
BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab PHASE1 This phase I trial studies the side effects and best dose of ubidecarenone ...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
A Safety Study of Orally Administered BPM31510 in Healthy Subjects PHASE1 This is an open-label, Phase I study of the bioavailability and safety of B...
Show More Learn More & Join Trial
Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older Adults With Sarcopenia EARLY_PHASE1 This study is being done to gather data on whether oral supplementation of ...
Show More Location
AdventHealth Translational Research Institute
Learn More & Join Trial
Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma N/A Glioblastoma is a rare, aggressive brain tumor that leads to death within 2...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) PHASE2 This is a single-arm, non-randomized, open-label Phase 2 therapeutic study ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients PHASE2 This is a Phase 2 multicenter, open-label, non-randomized study to examine ...
Show More Learn More & Join Trial